Company Raised Close to $400K
Mauldin, SC., February 3, 2023 –Xcelerate, Inc.
(OTCQBs: “XCRT”) today announced that it has closed its Reg A+ offering, raising almost $400,000 in additional equity financing. The Offering that was qualified on January 27, 2022.
“The Regulation A Tier 2 filing has served the Company well in its initial fundraising efforts. The proceeds have enabled Xcelerate, Inc. to complete audits, up-list to the QB Market, file an initial patent for its’ revolutionary surgical drill and structure a controlling interest in AfiyaSasa Africa, LLC” said Michael O’Shea, Xcelerate’ s CEO. “Now, as the Company embarks on a program of identifying potential revenue producing acquisitions, the Board has determined that Xcelerate and its shareholders would be better served by developing a more robust, structured capital program. In conjunction with our financial advisors we have begun reviewing our options” Mr. O’Shea concluded.
ABOUT XCELERATE INC.
In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries initially in Africa to provide for their population to obtain medical care by extending the reach of physicians through the use of that technology.
For more information:
Michael O’Shea, CEO, 854-900-2020
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.